<DOC>
	<DOCNO>NCT00688662</DOCNO>
	<brief_summary>The Evaluating Predictors &amp; Interventions Sphincter Oddi Dysfunction ( SOD ) study ( EPISOD ) randomize sham-controlled study biliary pancreatic sphincterotomy treatment patient pain cholecystectomy fitting criterion sphincter Oddi dysfunction type III .</brief_summary>
	<brief_title>Evaluating Predictors &amp; Interventions Sphincter Oddi Dysfunction</brief_title>
	<detailed_description>Clinical Trial Phase : Phase III Study Sites Seven clinical center US Study Period Planned enrollment period - 3 year Planned duration study - 5 year Study Population SOD III Patients Primary Study Objective : To ascertain whether subject SOD III respond sphincterotomy , Secondary Study Objectives To evaluate : - association result Sphincter Oddi Manometry ( SOM ) ( abnormal/normal ) primary outcome ( success/failure ) ; - success rate ( define primary ) subject receive biliary sphincterotomy alone versus subject receive biliary pancreatic sphincterotomy subgroup patient manometrically proven hypertension pancreatic sphincter ; - effect pre-specified prognostic factor primary outcome ; - anxiety depression score time relation study outcome ; - economic impact SOD III , endoscopic sphincterotomy patient SOD III ; , , - conduct careful follow-up study ( EPISOD2 ) standard care treatment ( separate protocol ) . Study Design The EPISOD Trial parallel , randomize , double-blinded , sham-controlled , multicenter Phase III clinical trial endoscopic sphincterotomy treatment adult 18 65 year age diagnose SOD III . Sample Size A minimum 214 subject randomize use 2:1 allocation favor sphincterotomy follow 12 month post-randomization .</detailed_description>
	<mesh_term>Sphincter Oddi Dysfunction</mesh_term>
	<criteria>1 . Patients diagnose clinical syndrome SOD , define Modified Functional Biliary Disorders Module Rome III criteria 2 . Pain burden Grade 3 high RAPID Questionnaire . 3 . Cholecystectomy 90 day enrollment . 4 . Laboratory Tests : Results blood test take within 1 week precede baseline visit others available precede 6 month ( postcholecystectomy ) : Direct bilirubin , alkaline phosphatase , amylase lipase result must great 2 X upper level normal.Transaminase level 3 X upper limit normal . If transaminase elevate ( &lt; 2X ULN ) association pain attack , return normal within 3 day . 5 . Normal abdominal imaging CT MR/MRCP bile duct report â‰¤9mm . 6 . Upper endoscopy examination without finding explain pain . 7 . Pain persist despite one trial acid suppressant medication one month ( tolerate ) . 8 . Pain persist despite trial antispasmodic . 9 . Subjects antidepressants pain control ( require ) take minimum one month prior baseline assessment . 9.Patients SOD depressive and/or anxiety disorder receive psychopharmacologic treatment must stable medication dose least 6 week . 10.Access telephone . 11.Must able speak , read , write English . 12.Signed date informed consent . 1 . Prior ERCP treatment . 2 . Age &lt; 18 Age &gt; 65 . 3 . Pregnancy : Women pregnant time Screening* exclude study . ( *Note : Women become pregnant AFTER Baseline Visit/ERCP allow remain study telephone followup visit ) . 4 . Prior gastric resection surgery involve biliary diversion . 5 . Prior diagnosis acute pancreatitis ( lipase &gt; 3 x ULN ) include postERCP pancreatitis , chronic pancreatitis radiological imaging , EUS 5 criterion , Cambridge criterion moderate ERCP . 6 . Daily use prescription analgesic previous month . 7 . Abdominal discomfort every day past month level 3 scale 110 . 8 . Presence significant psychiatric disorder : 1 . Lifetime psychotic disorder , bipolar disorder ; 2 . Substance use disorder within 6 month ; 3 . Eating disorder within 2 year 4 . Moderate &amp; severe depression define BDIII ( Beck Depression Inventory ) cutoff score &gt; 22 ( unless receive stable psychiatric therapy six week ) ; and/or , 5 . Suicidal risk ( equal great `` low '' ) use MINI suicide section score great 0 question 9 BDI . 9 . The total number day previous 3 month subject take prescription analgesic due episode abdominal pain great total number day subject episodes abdominal pain . 10 . Any condition , investigator 's opinion , make subject unsuitable study participation . ERCP Criteria : 1 . Pancreas divisum ( complete partial ) ( know discover study ERCP ) . 2 . Any pathology find ERCP ( except sphincter hypertension ) . 3 . Failed pancreatic manometry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Sphincter Oddi Dysfunction</keyword>
	<keyword>Pancreatitis</keyword>
	<keyword>Sphincterotomy</keyword>
</DOC>